Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment

Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment

Background: This study aimed to determine the effect of Hyper-Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone (CVAD) in the treatment of acute lymphoblastic leukemia (ALL) patients and remission duration. Materials and Methods: During a cross-sectional study in the Seyed Al-Shohada Hosp...

Full description

Bibliographic Details
Main Authors: Valiollah Mehrzad, Abbas Ahmadifar, Mehdi Mahmoudzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Advanced Biomedical Research
Subjects:
Acute lymphoblastic leukemia
Hyper Cyclophosphamide
Vincristine
Adriamycin
and Dexamethasone
recurrence
survival
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=81;epage=81;aulast=Mehrzad

Internet

http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=81;epage=81;aulast=Mehrzad

Similar Items